Pathophysiology
Literature review indicates that all intrathecal drugs have potential for granuloma formation, with no drug demonstrating a granuloma-inhibiting effect [PMID:37367712].
The Polyanalgesic Consensus Conference (PMID:22494332) highlights that the use of chronic intrathecal opioids is associated with the development of noninfectious inflammatory masses at the intrathecal catheter tip.
Diagnosis
The consensus emphasizes the importance of early detection of these space-occupying lesions (PMID:22494332) to avoid potentially devastating neurologic sequelae.
Management
A case report details CTG formation with ultralow-dose (0.6 mg/d) and low-concentration (1.2 mg/mL) morphine, highlighting the necessity for routine monitoring and prompt evaluation [PMID:37367712].
The panel recommends focusing on prevention, early detection, and effective management strategies for intraspinal granulomas when administering intrathecal drug therapy (PMID:22494332).
Complications
The case described experienced worsening sensorimotor deficits due to spinal cord compression from a granuloma formed during ultralow-dose morphine infusion [PMID:37367712].
References
1 Gui M, Sehgal N. Symptomatic Intrathecal Catheter Tip Granuloma Formation With Ultralow-Dose and Low-Concentration Morphine Infusion: A Case Report and Review of Literature. Neuromodulation : journal of the International Neuromodulation Society 2023. link 2 Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A et al.. Polyanalgesic Consensus Conference--2012: consensus on diagnosis, detection, and treatment of catheter-tip granulomas (inflammatory masses). Neuromodulation : journal of the International Neuromodulation Society 2012. link
2 papers cited of 3 indexed.